CIENCIASMEDICASNEWS: diciembre 2022

Find Clinical Trials Interested in volunteering for research on Alzheimer’s disease, related dementias, and cognitive health? Learn about new and featured studies below or search for clinical trials and studies near you with the Alzheimers.gov Clinical Trials Finder. New and featured studies Click on the trial name for details and contact information. Caregiving Mindfulness Program To Reduce Depression in Dementia Caregivers (Saint Paul, MN) SilverBills: A Financial and Legal Tool for Dementia Caregivers (online) SoCal Savvy: Dementia Caregiver Education Program (Los Angeles, CA) Tele-STELLA: Online Family Caregiver Program To Reduce Distressing Dementia Behaviors (online) Drugs Safety and Effects of LY3372993 for Alzheimer's Disease (multiple locations) Trappsol Cyclo for Early-Stage Alzheimer's Disease (multiple locations) Valacyclovir for Mild Cognitive Impairment (New York, NY) Cognitive Training and Brain Stimulation Cognitive-Motor Training To Improve Mobility in Healthy Older Adults (Washington, D.C.) Non-Invasive Brain Stimulation To Improve Memory (Minneapolis, MN) Featured Registries and Matching Services Asian Cohort for Alzheimer's Disease (ACAD) — Sign up to join a study to identify risk factors associated with Alzheimer's in people of Asian ancestry. MindCrowd — Enroll to take a brief online cognition test and join a registry to be contacted about future research studies on the aging brain. Trial-Ready Cohort — Down Syndrome — Enroll to help improve methods for tracking Alzheimer’s disease progression in people with Down syndrome through cognitive and clinical testing, genetic and biomarker testing, brain imaging, and other tests. Get more information about these and other Alzheimer’s clinical trials online. Or, call the ADEAR Center at 800-438-4380 or email adear@nia.nih.gov.

COVID-19 Noticias / Opiniones CHEQUEADAS EN INGLÉS y otros idiomas

New immune culprit discovered in Alzheimer's disease

COVID-19 Informes Científicos CHEQUEADOS COMPLETOS REVISADOS (full texts)

Daily temperature effects on under-five mortality in a tropical climate country and the role of local characteristics - PubMed

Impact of Hurricanes and Associated Extreme Weather Events on Cardiovascular Health: A Scoping Review - PubMed

Risk assessment of pollen allergy in urban environments - PubMed

Evaluation and management of gastroesophageal reflux disease: A brief look at the updated guidelines | Cleveland Clinic Journal of Medicine

Phase IIb Randomized, Placebo-Controlled, Dose-Escalating, Double-Blind Study of Cannabidiol Oil for the Relief of Symptoms in Advanced Cancer (MedCan1-CBD) | Journal of Clinical Oncology

Vestibular suppressants for benign paroxysmal positional vertigo: A systematic review and meta‐analysis of randomized controlled trials - Sharif - Academic Emergency Medicine - Wiley Online Library

Some Imported Dietary Supplements and Nonprescription Drug Products May Harm You | FDA

FDA approves first adenoviral vector-based gene therapy for high-risk Bacillus Calmette-Guérin unresponsive non-muscle invasive bladder cancer | FDA

Early tranexamic acid administration tied to fewer haemorrhage-related deaths

Coronary heart disease: replace sedentary time with physical activity

Long COVID: average prevalence of 45%, with highest rate in Europe

Recent Medical News & Clinical Studies | Univadis

Tumor Grade: Image Details - NCI Visuals Online

lunes, 19 de diciembre de 2022

Study shows positive effect of concentrating surgery for children with neuroblastoma

The impact of multimorbidity, smoking status, and demographics on vaccine hesitancy among pregnant women in Wales

Low ET levels in blood plasma may predict increased risk of cognitive impairment, dementia

Newly discovered mechanism could explain memory impairment in epilepsy

First H5N3 infection in a captive emperor tamarin documented in new study

Metformin use associated with lower risk of joint replacement in people with type 2 diabetes

How Can Virtual Reality Aid Physical Therapy?

Treatment-Resistant Depression Ups Risk for Comorbidities, Death

COVID-19 Vaccines Halve Risk for Reinfection and Severe Disease

Top Neurology Studies to Know

Philadelphia Schools to Require Masks After Winter Break

Rise of 'Alarming' Subvariants of COVID 'Worrisome' for Winter

Oncologists Overwhelmed; Cluster Headaches; and Liver Cancer Cost

Fitbit Figures: More Steps Per Day Cut Type 2 Diabetes Risk

Pharmacokinetically Guided Dosing: The Way Forward?

domingo, 18 de diciembre de 2022

Specific PHGKB|Reproductive and Child Health PHGKB|PHGKB

Specific PHGKB|HLBS|PHGKB-Heart, Lung, Blood and Sleep Diseases

Specific PHGKB|HLBS|PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Specific PHGKB|Cancer|PHGKB

Specific PHGKB|Infectious Diseases|PHGKB

Specific PHGKB|<bean:write name="specificPHGKBForm" property="topic" />|PHGKB

CDC-Authored Publications Update|PHGKB

Precision Health Database| Non-Genomics Precision Health Weekly Scan|PHGKB

Advanced Molecular Detection Clips Database|AMD Clips|PHGKB

Precision Health Database| Genomics Precision Health Weekly Scan|PHGKB

The Use of Cell-free DNA in Clinical Practice: Work in Progress | Blogs | CDC

Topics in Public Health Genomics: public health genomics | Search Results | Blogs | CDC

public health genomics | Search Results | Blogs | CDC

OGPPH Achievements (1997 - present) | CDC

Twenty-Five Years of Public Health Genomics: A Mini Symposium | CDC February 9, 2023, 12:00 pm -2:00 pm ET

Twenty-Five Years of Public Health Genomics: A Mini Symposium | CDC

Public Health Genomics at the Centers for Disease Control and Prevention: Happy 25th Anniversary! | Blogs | CDC

sábado, 17 de diciembre de 2022

Childhood Cervical and Vaginal Cancer Treatment (PDQ®)–Health Professional Version - NCI

Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ®)–Health Professional Version - NCI

Childhood Bladder Cancer Treatment (PDQ®)–Health Professional Version - NCI

Childhood Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version - NCI

Primary CNS Lymphoma Treatment (PDQ®)–Health Professional Version - NCI

Ebola Vaccine Regimens Safe, Immunogenic in Adults and Children | NIH: National Institute of Allergy and Infectious Diseases

NCI Minute: Health Benefits from Black Tea

Cancer Survivorship | Did You Know?

NIH launches harm reduction research network to prevent overdose fatalities | National Institutes of Health (NIH)

Chemo Drug Redesigned to Avoid Side Effects - NCI

Red Yeast Rice | NCCIH

Monarch system – MONARCH airway clearance system

Air pollution particles appear to weaken lung’s immune defenses over time | NHLBI, NIH

Study challenges “good” cholesterol’s role in universally predicting heart disease risk | NHLBI, NIH

Most reported substance use among adolescents held steady in 2022 | National Institutes of Health (NIH)

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal | FDA

Brentuximab Approved for High-Risk Hodgkin Lymphoma in Children - NCI

Paediatric migraine increases risk of mental health problems

Migraine: what constitutes triptan failure?

Novel Nasal Spray for Acute Migraine Disappoints in Phase 3 Trial

Symptom overlap between migraine with aura, stroke can confound diagnosis

Stress Key to the Link Between Computer Vision Syndrome and Migraine, Insomnia

Calling out colorectal cancer | NIH MedlinePlus Magazine

Stories from the lab: Researchers discuss innovative treatments for cancers of the blood

Intensive lowering of systolic blood pressure beneficial for patients with diabetes/hypertension

Diabetes plus elevated blood pressure in pregnancy is a risky combination

NYHA heart failure classification often inaccurate

Automated nudge to clinicians boosts statin prescribing in primary care

Type 1 diabetes: guidelines vs practice for cardiovascular risk management

Latest Clinical Research & Medical News | Univadis Global

RSV wave hammers hospitals — but vaccines and treatments are coming

FDA Approves First Gene Therapy for the Treatment of High-Risk, Non-Muscle-Invasive Bladder Cancer | FDA

FDA approves imaging drug to help identify lung cancer lesions | FDA

3+ million lives saved: COVID vaccines prevented mass death in the US - Genetic Literacy Project

Healthy Weight | HIV/AIDS | mRNA Influenza Vaccine | Cancer Screening | Heart Health

Should You Give Kids Medicine for Coughs and Colds? | FDA

jueves, 15 de diciembre de 2022

Behavioral Modification Could Prevent Nearly 50% of Cancer Deaths

Seizures in Dementia Hasten Decline and Death

High Lipoprotein(a) Levels Plus Hypertension Add to CVD Risk

The New Obesity Breakthrough Drugs

Scientists blast tumors with bubbles in the bloodstream - ISRAEL21c

Devices that deliver injectable drugs right at home - ISRAEL21c

Artificial intelligence tools help scientists decode genomic disorders and communicate genomic risks

Neural network classifiers for images of genetic conditions with cutaneous manifestations - PMC

Identifying facial phenotypes of genetic disorders using deep learning | Nature Medicine

Detecting repeated cancer evolution from multi-region tumor sequencing data | Nature Methods

Artificial Intelligence, Machine Learning and Genomics

Human Gene Therapy | Ahead of Print

Statement from Monica M. Bertagnolli, M.D., Director, National Cancer Institutes, National Institutes of Health | National Institutes of Health (NIH)

Investigating Ganitumab and Trametinib for Rhabdomyosarcoma - NCI

NIH-funded study finds hepatitis C treatment gap for individuals with alcohol use disorder | National Institutes of Health (NIH)

Fewer Radiation Treatments | Weight-Loss Surgery | Survivorship Video, 12/14/2022

NIAID Pandemic Autopsy Study Fosters Long COVID Treatment Trial | NIH: National Institute of Allergy and Infectious Diseases

AI may revolutionize rheumatic heart disease early diagnosis - Children's National

Ebola vaccine regimens safe, immunogenic in adults and children | National Institutes of Health (NIH)

A species of rat without the Y chromosome may foreshadow what might evolve in humans - Genetic Literacy Project

miércoles, 14 de diciembre de 2022

Polymorphisms in human immunoglobulin heavy chain genes can influence the function of SARS-CoV-2 neutralizing antibodies

XBB Omicron variant evades vaccine-induced immunity

Press Reset on Stress

Latest Clinical Research & Medical News | Univadis Global

New Study Explores How Instructions and Learning Affect Pain Perception and the Brain | NCCIH

Type 2 Diabetes and Dietary Supplements | NCCIH

NIH’s All of Us Research Program returns genetic health-related results to participants | National Institutes of Health (NIH)

Cancer Moonshot Seminar Series - NCI

Overcoming Drug Resistance - Cancer Moonshot Recommendation - NCI

Endocarditis in patients with cocaine or opioid use disorder saw marked increase between 2011 to 2022 | National Institutes of Health (NIH)

Protect Your Family From Fraudulent Flu Products | FDA

Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project

Request for Proposals (RFP) on Clinical Site Monitoring and Data Management Services for The Biomarkers Consortium Kidney Safety Project The National Institute of Mental Health is delighted to be a partner on the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ). The Foundation for the National Institutes of Health (NIH) is requesting information on Phase 2-ready compounds with a compelling biological hypothesis to address biological or clinical outcomes in the earliest stages of schizophrenia. This high-level overview is requested to inform on the selection of compounds for use in a biomarker focused proof of principle trial(s). The AMP SCZ project team looks forward to receiving your proposals and submissions by February 3, 2023!